Leo Cancer Care Raises $65M to Deploy Upright Proton Therapy System

Leo Cancer Care has raised $65 million to deploy its upright proton therapy system, designed to reduce treatment costs and facility footprint.

• The funding will support the rollout of the company's upright positioning proton therapy technology.
• The system aims to make proton therapy more accessible by minimizing installation space requirements.
• No specifics on deployment timeline or clinical sites were provided in the announcement.

RadPigeon summaries are original and for information only. They are not clinical advice.